← Leaderboards
James M Schumacher
Mclean Hospital
$2,292,036
Attributed
$9,168,144
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2020–24$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,168,144 · 1
By mechanism
U01$9,168,144 · 1
Top collaborators
- Penelope Jane Hallett7 shared
- Ole Isacson7 shared
- Oliver Cooper4 shared
- Anna Charlotta Teresia Magnuson Osborn3 shared
Most similar at Mclean Hospital
Same institution · by research overlap
- Ole Isacson$16,866,444
- Penelope Jane Hallett$5,641,169
- Sangmi Chung$8,912,133
- Oliver Cooper$1,431,036
- Anna Charlotta Teresia Magnuson Osborn$861,000
Others in their field
Other Emerging Leaders on “Freezing”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Thomas Steinbach · Experimental Pathology Laboratories$20,874,501
- Hemali Phatnani · New York University School Of Medicine$9,530,112
- Aina E. Cohen · Stanford University$9,121,454
- Thomas Denny · Duke University$9,088,186
- Tilal Khalil · Leidos Biomedical Research, Inc.$7,541,397
Research focus
FreezingInnovationDopaminergic CellFirst-In-HumanImmunosuppressionInduced Pluripotent Stem CellAutologousDevicesExcipientsFetus CellFunctional RestorationGenerationsBiodistributionCellsCell TherapyCell TransplantationCyclic GmpClinicAutologous TransplantationDopaminergic NeuronClinical TrialsBrainCryopreservationL-Dopa Induced Dyskinesia
Grant awards (7)
Parkinsons Disease Scalable iPSC Autologous Cell Therapy$1,958,850
U01 · FY2024 · NS
Parkinsons Disease Scalable iPSC Autologous Cell Therapy$1,961,294
U01 · FY2023 · NS
Parkinsons disease scalable iPSC autologous cell therapy$164,000
U01 · FY2023 · NS
Parkinsons Disease Scalable iPSC Autologous Cell Therapy$1,640,000
U01 · FY2022 · NS
Parkinsons disease scalable iPSC autologous cell therapy$164,000
U01 · FY2022 · NS
Parkinsons disease scalable iPSC autologous cell therapy$1,640,000
U01 · FY2021 · NS
Parkinsons disease scalable iPSC autologous cell therapy$1,640,000
U01 · FY2020 · NS